Figures computed from official regulatory filings — .
Analysttarget 53.5 USD (+464%) · consensus 4.67/5 · 3 buy · 0 hold · 0 sell
Ownershipinsiders 8.11% · institutions 50.11% · short 21.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for PALATIN TECHNOLOGIES INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
78 buys43 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| DUNTON ALAN Wtrack record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) |
| Morris Arlenetrack record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PRENDERGAST JOHN K Atrack record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| SPANA CARLtrack record | Other | $1.4K | SEC |
| WILLS STEPHEN Ttrack record | Other | $258.9 | SEC |
| WILLS STEPHEN Ttrack record | Other | $1.3K | SEC |
| SPANA CARLtrack record | Other | $2K | SEC |
| WILLS STEPHEN Ttrack record | Other | $925.9 | SEC |
| SPANA CARLtrack record | Other | $388.4 | SEC |
| WILLS STEPHEN Ttrack record | Other | $1.9K | SEC |
| SPANA CARLtrack record | Other | $3.1K | SEC |
| SPANA CARLtrack record | Other | $855.2 | SEC |
| WILLS STEPHEN Ttrack record | Other | $555.9 | SEC |
| WILLS STEPHEN Ttrack record | Other | $2K | SEC |
| SPANA CARLtrack record | Other | $3K | SEC |
| WILLS STEPHEN Ttrack record | Sell | $9.5K | SEC |
| SPANA CARLtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| DUNTON ALAN Wtrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WILLS STEPHEN Ttrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PRENDERGAST JOHN K Atrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WILLS STEPHEN Ttrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| SPANA CARLtrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WILLS STEPHEN Ttrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WILLS STEPHEN Ttrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PRENDERGAST JOHN K Atrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |